Voyager Therapeutics (VYGR) Interest Coverage Ratio (2014 - 2026)
Voyager Therapeutics (VYGR) posted Interest Coverage Ratio of 0.75 for Q1 2026, down 266.16% sequentially from 0.21 in Q4 2025, and up 96.85% YoY from 0.38 in Q1 2025.
Voyager Therapeutics (VYGR) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported Interest Coverage Ratio for 13 years, with the latest figure at 0.75 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 96.85% year-over-year to 0.75 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.17 (up 95.47% YoY) and the FY2025 annual result came in at 0.91, down 15.28% from the prior year.
- Interest Coverage Ratio retreated to 0.75 in Q1 2026 per VYGR's latest filing, from 0.21 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 11.56 in Q1 2023 and troughed at 30.61 in Q4 2024.
- A 5-year average of 3.59 and a median of 0.91 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio jumped 691.06% in 2022, then sank 4778.14% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 0.21 in 2022, then surged by 412.78% to 0.65 in 2023, then tumbled by 4778.14% to 30.61 in 2024, then jumped by 99.33% to 0.21 in 2025, then plunged by 266.16% to 0.75 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.75, 0.21, and 3.83 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Voyager Therapeutics | 201.32 Mn | 84.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.70 |
| Mar 31, 2026 | -0.75 |
| Dec 31, 2025 | -0.21 |
| Sep 30, 2025 | -3.83 |
| Jun 30, 2025 | -0.77 |
| Mar 31, 2025 | -23.89 |
| Dec 31, 2024 | -30.61 |
| Sep 30, 2024 | -3.67 |
| Jun 30, 2024 | -1.58 |
| Mar 31, 2024 | -0.91 |
| Dec 31, 2023 | 0.65 |
| Sep 30, 2023 | -3.16 |
| Jun 30, 2023 | -0.85 |
| Mar 31, 2023 | 11.56 |
| Dec 31, 2022 | -0.21 |
| Sep 30, 2022 | 2.54 |
| Jun 30, 2022 | -3.27 |
| Mar 31, 2022 | -2.12 |
| Dec 31, 2021 | 518.36 |
| Sep 30, 2021 | -0.43 |